Integrating Governance into Risk-Based Monitoring
The traditional model of 100% source data verification at every clinical site is no longer sustainable for modern trials. Sponsors and CROs now employ risk-based monitoring (RBM) strategies to focus resources on the most critical data, processes, and sites. However, as monitoring becomes more selective, the role of governance becomes even more vital.
Click to read the full article.
